Vaccinex, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Vaccinex, Inc. (VCNX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $5.75 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-04-15
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $8.21, a 1952.50% increase year-over-year.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.40, a 69.70% decline year-over-year.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $1.32, a 61.18% decline year-over-year.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2021-03-31 was $3.40, a 45.69% decline year-over-year.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $5.75, a 93.22% decline from fiscal 2023.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $84.81, a 64.97% decline from fiscal 2022.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $242.08, a 9700.81% increase from fiscal 2021.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $2.47, a 44.49% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $5.75 10-K · filed 2025-04-15 | ||||
| 2024-09-30 | $5.75 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | $5.75 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | $8.21 10-Q · filed 2024-05-15 | ||||
| 2023-12-31 | $84.81 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $6.06 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | $0.40 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $0.40 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $242.08 10-K/A · filed 2024-04-25 | $1.15 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $1.18 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $1.21 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | $1.32 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $2.47 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $2.53 10-Q · filed 2021-11-08 | ||||
| 2021-06-30 | $2.54 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | $3.40 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $4.45 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $4.50 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | $4.36 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | $6.26 10-Q · filed 2020-05-14 | ||||
| 2019-12-31 | $5.02 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $5.02 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $4.96 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $3.97 10-Q · filed 2019-05-15 | ||||
| 2018-12-31 | $13.10 10-K · filed 2020-03-09 | ||||
| 2018-09-30 | $13.60 10-Q · filed 2018-11-13 | ||||
| 2018-06-30 | $13.60 10-Q · filed 2018-08-14 | ||||
| 2017-12-31 | $13.60 10-K · filed 2019-03-13 |